Not applicableStudy completedNCT07305285What this trial is testingRoy Adaptation Model Improves Mood and QOL After Giant Acoustic NeuromaWho this might be right forAcoustic NeuromaFacial Paralysis West China Hospital 160
Testing effectiveness (Phase 2)Study completedNCT00004073What this trial is testingSuramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 54
Large-scale testing (Phase 3)Active Not RecruitingNCT04488822What this trial is testingThe Efficacy and Safety of Pexidartinib in Adult Subjects With TGCTWho this might be right forTenosynovial Giant Cell Tumor Daiichi Sankyo Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT03150862What this trial is testingA Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent GlioblastomaWho this might be right forBrain and Central Nervous System Tumors BeiGene USA, Inc. 116
Testing effectiveness (Phase 2)WithdrawnNCT05218408What this trial is testingCYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild TypeWho this might be right forAstrocytoma, Grade IVGlioblastomaGiant Cell Glioblastoma+1 more Celularity Incorporated
Testing effectiveness (Phase 2)Ended earlyNCT04938180What this trial is testingIntravenous AMB-05X in Tenosynovial Giant Cell Tumor PatientsWho this might be right forTenosynovial Giant Cell TumorPigmented Villonodular SynovitisTGCT+1 more AmMax Bio, Inc. 4
Large-scale testing (Phase 3)Study completedNCT00017147What this trial is testingS0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or GliosarcomaWho this might be right forMalignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System SWOG Cancer Research Network 183
Testing effectiveness (Phase 2)Study completedNCT00045708What this trial is testingA Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade GliomasWho this might be right forAdult Anaplastic AstrocytomaAdult Giant Cell GlioblastomaAdult Gliosarcoma+1 more National Cancer Institute (NCI) 57
Testing effectiveness (Phase 2)Study completedNCT00629889What this trial is testingLevetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain TumorsWho this might be right forBrain and Central Nervous System TumorsSeizure Dr Andrea Rossetti 52
Early research (Phase 1)Looking for participantsNCT02390752What this trial is testingPhase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...Who this might be right forNeurofibroma, PlexiformPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Promyelocytic, Acute+1 more National Cancer Institute (NCI) 54
Early research (Phase 1)Study completedNCT00946335What this trial is testingABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS TumorsWho this might be right forChildhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+25 more National Cancer Institute (NCI) 31
Early research (Phase 1)Study completedNCT00049387What this trial is testingTipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaWho this might be right forAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma National Cancer Institute (NCI) 19
Large-scale testing (Phase 3)Study completedNCT00003916What this trial is testingStandard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With GliomaWho this might be right forBrain and Central Nervous System Tumors European Organisation for Research and Treatment of Cancer - EORTC 25
Testing effectiveness (Phase 2)Study completedNCT00335764What this trial is testingSorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or GliosarcomaWho this might be right forAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more National Cancer Institute (NCI) 92
Early research (Phase 1)Study completedNCT02337426What this trial is testingDimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forAdult Brain GlioblastomaAdult Giant Cell GlioblastomaAdult Gliosarcoma Virginia Commonwealth University 12
Large-scale testing (Phase 3)Ended earlyNCT00031798What this trial is testingMethylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain TumorsWho this might be right forBrain and Central Nervous System TumorsCognitive/Functional EffectsDepression+2 more Wake Forest University Health Sciences
Early research (Phase 1)Study completedNCT00390403What this trial is testingGossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Testing effectiveness (Phase 2)Study completedNCT03027388What this trial is testingProtein Phosphatase 2A Inhibitor, in Recurrent GlioblastomaWho this might be right forAstrocytoma, Grades II, III and IVGlioblastoma MultiformeGiant Cell Glioblastoma+2 more National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Study completedNCT00010049What this trial is testingImatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or MeningiomaWho this might be right forBrain and Central Nervous System Tumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 105
Not applicableStudy completedNCT00920738What this trial is testingMetabolic Syndrome in Childhood Cancer SurvivorsWho this might be right forBrain and Central Nervous System TumorsLeukemiaLymphoma+2 more University of Minnesota 512